CDK7-IN-13

Product Specifications

UNSPSC Description

CDK7-IN-13 is a potent inhibitor of CDK7. CDK7-IN-13 is a pyrimidinyl derivative compound. CDK7-IN-13 has the potential for the research of various cancers, especially the cancer with transcriptional dysregulation (extracted from patent CN114249712A, compound 1)[1].

Target Antigen

CDK

Type

Reference compound

Related Pathways

Cell Cycle/DNA Damage

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/cdk7-in-13.html

Solubility

10 mM in DMSO

Smiles

CS(C)(=O)=NC1=CC=CC2=C1NC=C2C3=NC(N[C@H]4CCCNC4)=NC=C3C(F)(F)F

Molecular Weight

452.50

References & Citations

[1]Guanpeng Qiu, et al. Pyrimidinyl derivatives, method for the production thereof and use thereof. Patent CN114249712A.

Shipping Conditions

Room temperature

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-147597/CDK7-IN-13-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-147597/

Clinical Information

No Development Reported

CAS Number

2765676-20-6

Curated Selection

Ask

View Details

NBP2-90540PE 0.1 mL

Rabbit Monoclonal EMMPRIN/CD147 Antibody (041) [PE]

Ask